搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
星島網
2 天
亚太青年领袖齐集亚太领袖高峰会 海外发展成趋势 人才办冀吸引来 ...
另一位来自新加坡南洋理工大学的Karthik ...
3 天
Monopar Therapeutics股票目标价上调,阿斯利康制药交易促使买入评级
周一,H.C. Wainwright将Monopar Therapeutics (NASDAQ:MNPR)的股票目标价从6.00美元大幅上调至22.00美元,同时重申了对该股的买入评级。这一修订是基于Monopar最近与阿斯利康制药达成的许可协议,获得了ALXN-1840(一种用于威尔逊氏病的候选药物)的全球独家许可。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Tapped for health secretary
Florida sues FEMA officials
Bohannan requests recount
Named grand marshal
FBI offering up to $25K
Vonn ending her retirement
To replace Kotb on 'Today'
E. coli cases climb to 104
To close hundreds of stores
Largest coral ever recorded
House GOP conference chair
Teen guilty of swatting calls
Judge blocks name change
Global increase in diabetes
Seeks pause in docs appeal
Remains ID'd after 82 years
Faces up to $165M penalty
Notre Dame set to reopen
Israeli airstrikes hit Syria
The Onion buys Infowars
DOJ report on Fulton jail
Ban on executives upheld
Briefly detained at airport
Gaetz resigns from Congress
Lawyers seek to quit case
FBI raids Coplan's home
China hacked telecom firms
Israel accused of war crimes
EU fines Meta
反馈